Urmann
Corinna Urmann, Deggendorf DE
Patent application number | Description | Published |
---|---|---|
20140349919 | CHROMANE-LIKE CYCLIC PRENYLFLAVONOIDS FOR THE MEDICAL INTERVENTION IN NEUROLOGICAL DISORDERS - The present invention relates to certain chromane-like cyclic prenylflavonoids, in particular the compounds of formulae (I), (II) and (III) as described and defined herein, for use in the treatment or prevention of a neurological disorder, as well as their use in promoting neuronal differentiation, neurite outgrowth and neuroprotection. | 11-27-2014 |
Daniel Urmann, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20130297338 | Method for Evaluating the Health of a Website - The invention is a health indicator that is used to evaluate a website. The health indicator is used to evaluate performance and compare the website to predicted performance, similar websites, and websites of entities in adjacent industries. This health indicator will allow for a single view/metric, signified by a unique word, color, number, symbol or an identifiable marker, of the performance and of the Internet site as it relates to Search Engine Optimization, e-Commerce, Bounce Rates, Traffic Data, Traffic Flow, Conversion Rates, Page Views, Social and Mobile metrics, Shopping Cart Information, and any additional data the analysis system has access to. | 11-07-2013 |
Jens Urmann, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20150236858 | Method for Creating a Derived Entity of an Original Data Carrier - There is provided a method for creating an authentication entity derived from an original data carrier, wherein the original data carrier has a key pair that is individual to the original data carrier and comprises a public key and a secret key of the original data carrier, and a certificate for the public key of the original data carrier. The method comprises the following steps: deriving a secret key for the derived authentication entity from the secret key of the original data carrier by the original data carrier; forming derivation data for the derived authentication entity; transferring authentication data to the derived authentication entity, wherein the authentication data have the derivation data, the certificate of the public key of the original data carrier as well as a derived key pair which comprises the derived secret key and the public key of the original data carrier. | 08-20-2015 |
Mathias Urmann, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20090054494 | N-[1,3,4]-THIADIAZOL-2-YL-BENZENE SULFONAMIDES, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR THEIR THERAPEUTIC USE - The present invention comprises N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, their physiologically acceptable salts and functional derivatives that exhibit peroxisome proliferator activated receptor (PPAR) PPARdelta and PPARgamma agonist activity. The structure of the compounds of the invention are defined by Formula I below, | 02-26-2009 |